TP53 and Hypercalcemia: In case p53 is mutated, a combination of small molecules reactivating mutant p53, such as PRIMA or MIRA-1 [56], together with calcitriol (or an analog to avoid hypercalcemia by high vitamin D3 doses) may lead to the inhibition of cancer progression.